Compounds > selegiline
Page last updated: 2024-08-23

selegiline and Liver Dysfunction

selegiline has been researched along with Liver Dysfunction in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bonuccelli, U; Del Dotto, P1
Anttila, M; Pelkonen, O; Rautio, A; Sotaniemi, EA1

Reviews

1 review(s) available for selegiline and Liver Dysfunction

ArticleYear
Clinical pharmacokinetics of cabergoline.
    Clinical pharmacokinetics, 2003, Volume: 42, Issue:7

    Topics: Age Factors; Antiparkinson Agents; Cabergoline; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Ergolines; Female; Food-Drug Interactions; Humans; Kidney Diseases; Levodopa; Liver Diseases; Male; Selegiline; Sex Factors

2003

Other Studies

1 other study(ies) available for selegiline and Liver Dysfunction

ArticleYear
Marked effect of liver and kidney function on the pharmacokinetics of selegiline.
    Clinical pharmacology and therapeutics, 2005, Volume: 77, Issue:1

    Topics: Aged; Area Under Curve; Biotransformation; Case-Control Studies; Female; Humans; Kidney; Kidney Function Tests; Liver Diseases; Liver Function Tests; Male; Middle Aged; Monoamine Oxidase Inhibitors; Selegiline

2005